of cell cycle control,
apoptosis and resistance to treatment, and the possible use of miRNAs in clinical
BAO, Z.,
HAN, Z.,
ZHANG, B.,
YU, Y.,
XU, Z.,
MA, W.,
DING, F.,
ZHANG, L.,
YU, M.,
LIU, S.,
JIN, M.,
YAN, G.,
HUANG, Q.,
WANG, X.,
HUA, B.,
YANG, F.,
LI, Y.,
LIU, Y.,
LI, B.,
WANG, N.,
CAI, B.,
ZAGIDULLIN, N.,
CARVALHO, K. (2019) -actininindifferentiatedhiPSCs.Furthermore,ATOtreatmenthadcausedDNAdamage which was shown in the upregulation of γH2AX, a sensitive
marker for DNA double-strand breaks. Taken
FACHAL, L.,
KAR, S.,
TYRER, J.P.,
GHOUSSAINI, M.,
HARRINGTON, P.A.,
HEALEY, C.S.,
MAYES, R.,
SHAH, M.,
PHAROAH, P.D.P.,
EASTON, D.F.,
DUNNING, A.M.,
ASCHARD, H.,
JIANG, X.,
TAMIMI, R.M.,
KHUSNUTDINOVA, E.,
BIAŁKOWSKA, K.,
и др. соавторы (2020) . Known cancer drivers, transcription factors and genes in the developmental,
apoptosis, immune system
Yagudin, T.,
Zhao, Y.,
Gao, H.,
Zhang, Y.,
Yang, Y.,
Zhang, X.,
Ma, W.,
Daba, T.M.,
Ishmetov, V.,
Kang, K.,
Yang, B.,
Pan, Z. (2020)
infarction in order to facilitate the development of novel therapy. Inhibitor of
apoptosisYagudin, T,
Zhao, Y,
Gao, HY,
Zhang, Y,
Yang, Y,
Zhang, XF,
Ma, WB,
Daba, TM,
Ishmetov, V,
Kang, K,
Yang, BF,
Pan, ZW (2021) infarction in order to facilitate the development of novel therapy. Inhibitor of
apoptosisGareev, Ilgiz,
Kudriashov, Valentin,
Sufianov, Albert,
Begliarzade, Sema,
Ilyasova, Tatiana,
Liang, Yanchaof,
Beylerli, Ozal (2022) the proliferation and
apoptosis of related cells and closely related to the development of atherosclerotic plaques
РОЛЬ КАРВЕДИЛОЛА В ПРЕДОТВРАЩЕНИИ АПОПТОЗА КАРДИОМИОЦИТОВ ПРИ ОСТРОМ ИНФАРКТЕ МИОКАРДАЗакирова, А.Н.,
Гарифуллин, Б.Н.,
Закирова, Н.Э.,
Zakirova, N.E.,
Garifullin, B.N.,
Zakirova, A.N. (2017) Data on the mechanisms of cardiomyocyte
apoptosis in myocardial infarction are presented. It has